GGrantIndex
← Leaderboards

Victor Valcour

University Of Hawaii At Manoa

Google Scholar ↗PubMed ↗ORCID ↗
$19,584,217
Attributed
$30,927,686
Total exposure
16
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,927,686 · 16

By mechanism

R01$25,811,727 · 7
T32$1,615,965 · 1
K24$886,636 · 1
R21$831,602 · 2
K23$643,380 · 1
UG3$558,193 · 1

Top collaborators

Most similar at University Of Hawaii At Manoa

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposNeuropsychological TestsCognitiveBrainAntiretroviral TherapyBaseEnrollmentHiv InfectionsMonocyteCohortS DiseasePlasmaImpaired CognitionLinkFundingImmuneNeurologicMild Cognitive ImpairmentPhenotypeThailandCognitionPublishingImageBrain Injuries

Grant awards (62)

Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA)$558,193
UG3 · FY2025 · AG · contact PI
Research Fellowship for Equity in Alzheimer's Disease and Brain Health$557,375
T32 · FY2025 · AG · contact PI
Research Training for Equity in Alzheimer's Disease and Brain Health in Colombia$243,207
D43 · FY2025 · TW · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$783,639
R01 · FY2024 · AG
Research Fellowship for Equity in Alzheimer's Disease and Brain Health$545,891
T32 · FY2024 · AG · contact PI
Research Training for Equity in Alzheimer's Disease and Brain Health in Colombia$247,275
D43 · FY2024 · TW · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$99,012
R01 · FY2024 · AG
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$63,017
R01 · FY2024 · AG
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$795,857
R01 · FY2023 · AG
Research Fellowship for Equity in Alzheimer's Disease and Brain Health$344,773
T32 · FY2023 · AG · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$126,033
R01 · FY2023 · AG
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$807,613
R01 · FY2022 · AG
Research Fellowship for Equity in Alzheimer's Disease and Brain Health$167,926
T32 · FY2022 · AG · contact PI
Harnessing single cell epigenome-wide profiling of myeloid cells to compare and contrast Alzheimer's from HIV-associated cognitive dysfunction$63,017
R01 · FY2022 · AG
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60$1,093,727
R01 · FY2021 · MH · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$819,055
R01 · FY2021 · AG
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection$587,255
R01 · FY2021 · MH
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60$1,124,685
R01 · FY2020 · MH · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$863,930
R01 · FY2020 · AG
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection$601,753
R01 · FY2020 · MH
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60$1,122,349
R01 · FY2019 · MH · contact PI
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection$606,617
R01 · FY2019 · MH
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60$1,116,125
R01 · FY2018 · MH · contact PI
Interventions for Symptom Management in Older Patients with HAND$663,358
R01 · FY2018 · NR · contact PI
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection$613,053
R01 · FY2018 · MH
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60$1,064,206
R01 · FY2017 · MH · contact PI
Interventions for Symptom Management in Older Patients with HAND$671,128
R01 · FY2017 · NR · contact PI
Impact of Treatment on Brain Integrity in the Earliest Stages of HIV Infection$661,925
R01 · FY2017 · MH
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition$175,207
K24 · FY2017 · MH · contact PI
Interventions for Symptom Management in Older Patients with HAND$682,971
R01 · FY2016 · NR · contact PI
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition$176,320
K24 · FY2016 · MH · contact PI
Interventions for Symptom Management in Older Patients with HAND$677,214
R01 · FY2015 · NR · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$614,504
R01 · FY2015 · MH · contact PI
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition$177,403
K24 · FY2015 · MH · contact PI
Interventions for Symptom Management in Older Patients with HAND$759,023
R01 · FY2014 · NR · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$609,638
R01 · FY2014 · MH · contact PI
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study$590,759
R01 · FY2014 · MH · contact PI
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition$178,528
K24 · FY2014 · MH · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$590,811
R01 · FY2013 · MH · contact PI
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study$576,433
R01 · FY2013 · MH · contact PI
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition$179,178
K24 · FY2013 · MH · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$637,134
R01 · FY2012 · MH · contact PI
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study$618,681
R01 · FY2012 · MH · contact PI
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV$616,298
R01 · FY2012 · NS · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$24,676
R01 · FY2012 · MH · contact PI
Long-Term CNS Consequences of Treatment During Acute Infection$636,382
R01 · FY2011 · MH · contact PI
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study$623,860
R01 · FY2011 · MH · contact PI
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV$601,635
R01 · FY2011 · NS · contact PI
HIV CONNECTOMICS$37,247
P41 · FY2011 · RR · contact PI
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT study$661,176
R01 · FY2010 · MH · contact PI
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV$605,317
R01 · FY2010 · NS · contact PI
Dementia in HIV patients over 60 years of age$214,800
K23 · FY2010 · AG · contact PI
Central Nervous System Effects in Acute HIV Seroconversion$174,478
R21 · FY2010 · MH · contact PI
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV$658,773
R01 · FY2009 · NS · contact PI
Dementia in HIV patients over 60 years of age$214,480
K23 · FY2009 · AG · contact PI
Central Nervous System Effects in Acute HIV Seroconversion$193,020
R21 · FY2009 · MH · contact PI
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV$679,088
R01 · FY2008 · NS · contact PI
Dementia in HIV patients over 60 years of age$214,100
K23 · FY2008 · AG · contact PI
Macrophages, HAART, and HIV dementia in Thailand$215,842
R21 · FY2006 · MH · contact PI
Macrophages, HAART, and HIV dementia in Thailand$248,262
R21 · FY2005 · MH
NEUROCOGNITIVE FUNCTION: HIV SEROPOSITIVITY AND AGING$18,324
P20 · FY2005 · RR
NEUROCOGNITIVE FUNCTION: HIV SEROPOSITIVITY AND AGING$34,130
P20 · FY2004 · RR